Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments
Discussions regarding Executive Order regarding outbound investments
Discussions regarding S.3558/H.R.7085, the BIOSECURE Act
Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081
Discussions regarding the White House Executive Order on Artificial Intelligence (AI)
Duration: November 10, 2022
to
present
General Issues: Trade (Domestic & Foreign) , Health Issues , Computer Industry , Copyright/Patent/Trademark , Labor Issues/Antitrust/Workplace , Taxation/Internal Revenue Code
Spending: about $1,130,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: Commerce - Dept of (DOC), House of Representatives, U.S. Senate, White House Office, Federal Trade Commission (FTC), Treasury - Dept of
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Danaher Corporation had in-house lobbyists. The report was filed on April 22.
Original Filing: 301575497.xml
Lobbying Issues
Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments
Discussions regarding Executive Order regarding outbound investments
Discussions regarding S.3558/H.R.7085, the BIOSECURE Act
Agencies Lobbied
Commerce - Dept of (DOC) U.S. House of Representatives U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Discussions regarding the White House Executive Order on Artificial Intelligence (AI)
4th Quarter, 2023
In Q4, Danaher Corporation had in-house lobbyists. The report was filed on Jan. 22.
Original Filing: 301539447.xml
Lobbying Issues
Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments
Discussions regarding Executive Order regarding outbound investments
Agencies Lobbied
Commerce - Dept of (DOC) U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
3rd Quarter, 2023
In Q3, Danaher Corporation had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301512323.xml
Lobbying Issues
Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments
Discussions regarding Executive Order regarding outbound investments
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
2nd Quarter, 2023
In Q2, Danaher Corporation had in-house lobbyists. The report was filed on July 18, 2023.
Original Filing: 301480042.xml
Lobbying Issues
Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments
Discussions regarding Executive Order regarding outbound investments
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA)
Terminations of Public Health Emergency (PHE)
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
FTC Proposed Rule to Ban Non-competes, nationwide
Agencies Lobbied
U.S. Senate U.S. House of Representatives Federal Trade Commission (FTC)
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2023
In Q1, Danaher Corporation had in-house lobbyists. The report was filed on April 20, 2023.
Original Filing: 301464237.xml
Lobbying Issues
Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments
Discussions regarding Executive Order regarding outbound investments
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA)
Terminations of Public Health Emergency (PHE)
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
FTC Proposed Rule to Ban Non-competes, nationwide
Agencies Lobbied
U.S. Senate U.S. House of Representatives Federal Trade Commission (FTC)
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2022
In Q4, Danaher Corporation had in-house lobbyists. The report was filed on March 3, 2023.
Original Filing: 301447529.xml
Lobbying Issues
Implementation of corporate minimum tax
Agencies Lobbied
U.S. Senate U.S. House of Representatives Treasury - Dept of
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments
Discussions regarding Executive Order regarding outbound investments
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
4th Quarter, 2022
Danaher Corporation filed a lobbying registration on Dec. 19, 2022 for in-house lobbying efforts, effective Nov. 10, 2022.
Original Filing: 301424008.xml
Issue(s) they said they’d lobby about: Domestic and international tax policy including corporate minimum tax issues and Global Intangible Low Tax Income (GILTI). Tariffs, export controls, outbound investments. Biotechnology and biomanufacturing. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate